Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Topic collections
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Topic collections
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
intravitreal bevacizumab
Email alerts
intravitreal bevacizumab
Intravitreal bevacizumab improves the clearance of vitreous haemorrhage and visual outcomes in patients with proliferative diabetic retinopathy
Joonas
Wirkkala
,
Risto
Bloigu
,
Nina Maria
Hautala
BMJ Open Ophthalmology
Dec 2019,
4
(1)
e000390;
DOI:
10.1136/bmjophth-2019-000390
Special collections
BMJ Open Ophthalmology
Biomaterials
(2)
Cornea and Ocular Surface
(36)
Genetics
(8)
Glaucoma
(37)
Global Ophthalmology
(27)
Lens
(7)
Neuro-Ophthalmology
(11)
Ocular Oncology
(5)
Orbit and Oculoplastics
(6)
Paediatric Ophthalmology
(33)
Retina
(62)
Uveitis
(7)
Vision Science
(13)
COVID-19
(27)
Editor's choice
Guidelines, Recommendations and Consensus Statements
Press releases
